Buy Alert: 7-8% Sleep Well At Night Yields With Inflation-Beating Growth

JamesBrey With interest rates at elevated levels and inflation remaining stubbornly high, income-focused investors are becoming increasingly selective, preferring stocks that offer a yield with a comfortable spread above the current risk-free rate. This compensates for the additional risk associated with investing in equities. Additionally, investors seek high-yield stocks whose payouts not only keep pace…

Read More

Sleep Number: An Interesting Gamble, But Not A Value Play (NASDAQ:SNBR)

DragonImages/iStock via Getty Images Sleep Number (NASDAQ:SNBR) is an U.S. company specializing in innovative bedding solutions, particularly renowned for its adjustable mattresses. Users can customize the firmness or softness of their mattress according to their individual preferences, utilizing a remote control or a smartphone app to adjust the air pressure within the mattress chambers. Their…

Read More

3 Royalty Plays So You Can ‘Sleep Well At Night’

Thinkstock This article was coproduced with Leo Nelissen. It’s time to talk about a very important topic: value investing in the oil and gas industry. Generally speaking, we have become much more conservative when it comes to growth versus value investments, as the market has run hot in recent months. Using the JPMorgan (JPM) data…

Read More

ResMed: Putting GLP-1 Myths To Sleep (NYSE:RMD)

BrilliantEye/iStock via Getty Images Company Overview ResMed (NYSE:RMD) is a global leader in the digital health sector, distinguished by its extensive range of cloud-connected medical devices. The company has achieved a significant presence in the medical device market, with over 22.5 million cloud-connectable units sold in more than 140 countries. ResMed’s expertise primarily lies in…

Read More

SWAN Vs. IGLB: Which Helped You Sleep Better At Night?

Damir Khabirov/iStock via Getty Images On our last coverage of Amplify BlackSwan Growth & Treasury Core ETF (NYSEARCA:SWAN) we were less than thrilled with the setup and suggested investors should use the opportunity to move to another fund. Yes, while they may move differently at times than your other holdings, they don’t offer any advantage….

Read More

Idorsia’s Insomniac Earnings And The Sell Signal That Won’t Sleep (IDRSF)

Milko Reason for the Update: Q2 Earnings and Sell Rating Re-iteration Q2 2023 Earnings Overview Idorsia (OTC:IDRSF) provided its half-year 2023 financial revelations, which, unfortunately, failed to inspire confidence. The company ended with a meager CHF43.8M in cash, cash equivalents, and short-term deposits. Their sales were below expectations, and the withdrawal of the ambitious 2025…

Read More